90 related articles for article (PubMed ID: 20130454)
1. Cyclins D3 and E go hand in hand with Cdk4/6 in diffuse large B-cell lymphoma.
Gilmore TD; Thompson RC; Faber AC
Cell Cycle; 2010 Feb; 9(3):448-9. PubMed ID: 20130454
[No Abstract] [Full Text] [Related]
2. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E.
Gumina MR; Xu C; Chiles TC
Cell Cycle; 2010 Feb; 9(4):820-8. PubMed ID: 20107311
[TBL] [Abstract][Full Text] [Related]
3. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
[TBL] [Abstract][Full Text] [Related]
4. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.
Paternot S; Colleoni B; Bisteau X; Roger PP
Cell Cycle; 2014; 13(18):2879-88. PubMed ID: 25486476
[TBL] [Abstract][Full Text] [Related]
5. Fangchinoline induces G1 arrest in breast cancer cells through cell-cycle regulation.
Xing Z; Zhang Y; Zhang X; Yang Y; Ma Y; Pang D
Phytother Res; 2013 Dec; 27(12):1790-4. PubMed ID: 23401195
[TBL] [Abstract][Full Text] [Related]
6. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
[TBL] [Abstract][Full Text] [Related]
7. cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation.
Naderi S; Gützkow KB; Christoffersen J; Smeland EB; Blomhoff HK
Eur J Immunol; 2000 Jun; 30(6):1757-68. PubMed ID: 10898514
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
[TBL] [Abstract][Full Text] [Related]
9. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells.
Anders L; Ke N; Hydbring P; Choi YJ; Widlund HR; Chick JM; Zhai H; Vidal M; Gygi SP; Braun P; Sicinski P
Cancer Cell; 2011 Nov; 20(5):620-34. PubMed ID: 22094256
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
11. α-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation.
Yang L; Wen Y; Lv G; Lin Y; Tang J; Lu J; Zhang M; Liu W; Sun X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):325-331. PubMed ID: 28993193
[TBL] [Abstract][Full Text] [Related]
12. Cyclin independent role for cdk4/6 during B cell lymphoma survival.
Snow EC
Cell Cycle; 2010 Aug; 9(15):2932. PubMed ID: 20703096
[No Abstract] [Full Text] [Related]
13. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
14. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways.
Lin SL; Chang DC; Ying SY; Leu D; Wu DT
Cancer Res; 2010 Nov; 70(22):9473-82. PubMed ID: 21062975
[TBL] [Abstract][Full Text] [Related]
16. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
17. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
Tamir A; Petrocelli T; Stetler K; Chu W; Howard J; Croix BS; Slingerland J; Ben-David Y
Cell Growth Differ; 2000 May; 11(5):269-77. PubMed ID: 10845428
[TBL] [Abstract][Full Text] [Related]
18. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes.
Depoortere F; Van Keymeulen A; Lukas J; Costagliola S; Bartkova J; Dumont JE; Bartek J; Roger PP; Dremier S
J Cell Biol; 1998 Mar; 140(6):1427-39. PubMed ID: 9508775
[TBL] [Abstract][Full Text] [Related]
19. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]